Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker MCRB
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Kelly Brady See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 64 | $4.55 | $291 Sale | Form 4 ↗ |
| Aug 17, 2026 | Eric D. Shaff Director | MCRB Seres Therapeutics, Inc. | Sale | 263 | $4.55 | $1,197 Sale | Form 4 ↗ |
| Aug 17, 2026 | Matthew R. Henn See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 81 | $4.55 | $369 Sale | Form 4 ↗ |
| Aug 17, 2026 | Thomas DesRosier See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 82 | $4.55 | $373 Sale | Form 4 ↗ |
| May 18, 2026 | Eric D. Shaff Director | MCRB Seres Therapeutics, Inc. | Sale | 259 | $7.53 | $1,950 Sale | Form 4 ↗ |
| May 18, 2026 | Kelly Brady See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 59 | $7.53 | $444 Sale | Form 4 ↗ |
| May 18, 2026 | Thomas DesRosier See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 79 | $7.53 | $595 Sale | Form 4 ↗ |
| May 18, 2026 | Matthew R. Henn See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 77 | $7.53 | $580 Sale | Form 4 ↗ |
| Feb 15, 2026 | Teresa L. Young See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 75 | $8.47 | $635 Sale | Form 4 ↗ |
| Feb 15, 2026 | Eric D. Shaff Director | MCRB Seres Therapeutics, Inc. | Sale | 259 | $8.47 | $2,194 Sale | Form 4 ↗ |
| Feb 15, 2026 | Thomas DesRosier See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 78 | $8.47 | $661 Sale | Form 4 ↗ |
| Feb 15, 2026 | Matthew R. Henn See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 89 | $8.47 | $754 Sale | Form 4 ↗ |
| Nov 15, 2025 | Thomas DesRosier See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 76 | $17.30 | $1,315 Sale | Form 4 ↗ |
| Nov 15, 2025 | Teresa L. Young See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 1,042 | $17.30 | $18.0K Sale | Form 4 ↗ |
| Nov 15, 2025 | Eric D. Shaff Director | MCRB Seres Therapeutics, Inc. | Sale | 217 | $17.30 | $3,754 Sale | Form 4 ↗ |
| Nov 15, 2025 | Matthew R. Henn See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 1,257 | $17.30 | $21.7K Sale | Form 4 ↗ |
| Aug 18, 2025 | Thomas DesRosier See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 76 | $16.65 | $1,265 Sale | Form 4 ↗ |
| Aug 18, 2025 | Teresa L. Young See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 59 | $16.65 | $982 Sale | Form 4 ↗ |
| Aug 18, 2025 | Eric D. Shaff Director | MCRB Seres Therapeutics, Inc. | Sale | 217 | $16.65 | $3,613 Sale | Form 4 ↗ |
| Aug 18, 2025 | Matthew R. Henn See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 73 | $16.65 | $1,215 Sale | Form 4 ↗ |
| May 16, 2025 | Teresa L. Young See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 63 | $7.28 | $459 Sale | Form 4 ↗ |
| May 16, 2025 | Eric D. Shaff CEO and President, Director | MCRB Seres Therapeutics, Inc. | Sale | 220 | $7.28 | $1,602 Sale | Form 4 ↗ |
| May 16, 2025 | Matthew R. Henn See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 77 | $7.28 | $561 Sale | Form 4 ↗ |
| May 15, 2025 | Thomas DesRosier Chief Legal Officer and EVP | MCRB Seres Therapeutics, Inc. | Sale | 79 | $7.28 | $575 Sale | Form 4 ↗ |
| Feb 18, 2025 | Teresa L. Young See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 3,338 | $0.81 | $2,704 Sale | Form 4 ↗ |
| Feb 18, 2025 | Matthew R. Henn See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 3,953 | $0.81 | $3,202 Sale | Form 4 ↗ |
| Feb 18, 2025 | Eric D. Shaff CEO and President, Director | MCRB Seres Therapeutics, Inc. | Sale | 12,726 | $0.81 | $10.3K Sale | Form 4 ↗ |
| Feb 18, 2025 | Thomas DesRosier Chief Legal Officer and EVP | MCRB Seres Therapeutics, Inc. | Sale | 4,300 | $0.81 | $3,483 Sale | Form 4 ↗ |
| Feb 18, 2025 | Lisa von Moltke See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 4,416 | $0.81 | $3,577 Sale | Form 4 ↗ |
| Nov 18, 2024 | Thomas DesRosier Chief Legal Officer and EVP | MCRB Seres Therapeutics, Inc. | Sale | 878 | $0.54 | $474 Sale | Form 4 ↗ |
| Nov 18, 2024 | Lisa von Moltke See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 977 | $0.54 | $528 Sale | Form 4 ↗ |
| Nov 18, 2024 | Teresa L. Young See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 735 | $0.54 | $397 Sale | Form 4 ↗ |
| Nov 18, 2024 | Matthew R. Henn See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 927 | $0.54 | $501 Sale | Form 4 ↗ |
| Nov 18, 2024 | Eric D. Shaff CEO and President, Director | MCRB Seres Therapeutics, Inc. | Sale | 2,505 | $0.54 | $1,353 Sale | Form 4 ↗ |
| Oct 28, 2024 | Lisa von Moltke See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 4,334 | $0.69 | $2,990 Sale | Form 4 ↗ |
| Oct 28, 2024 | Matthew R. Henn See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 3,984 | $0.69 | $2,749 Sale | Form 4 ↗ |
| Oct 28, 2024 | Thomas DesRosier Chief Legal Officer and EVP | MCRB Seres Therapeutics, Inc. | Sale | 4,259 | $0.69 | $2,939 Sale | Form 4 ↗ |
| Oct 28, 2024 | Eric D. Shaff CEO and President, Director | MCRB Seres Therapeutics, Inc. | Sale | 8,748 | $0.69 | $6,036 Sale | Form 4 ↗ |
| Oct 28, 2024 | Teresa L. Young See Remarks | MCRB Seres Therapeutics, Inc. | Sale | 2,983 | $0.69 | $2,058 Sale | Form 4 ↗ |
39 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 7:14 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances